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Abstract 



The thesis entitled “Synthesis of naturally occurring and biologically active compounds” has been organised into four chapters.
 

Chapter-I :  Synthesis of linear furoquinoline alkaloids of dictamnine type. 

The extract of various plant species yielded furoquinoline alkaloids, which are shown to have anti microbial, ovicidal, mutagenecity, photobiological, anti cancer and insect anti-feedant activities. Several researchers have isolated furoquinoline alkaloids from different plant species. 



There are several reports on the synthesis of linear furoquinoline alkaloids. Grundon et al and Narasimhan et al have extensively contributed to the field of furoquinoline alkaloids. Based on the lines of   Narasimhan and co-workers, a new approach has been developed for the synthesis of four furoquinoline alkaloids (1-4), as outlined in Scheme-I. 

Scheme-I






Anilines(1a-d) were reacted with malonic acid and POCl3 to furnish 2,4-dichloroquinolines(2a-d), which were converted to the corresponding 2,4-dimethoxy quinolines (3a-d) with NaOMe. The 2,4-dimethoxyquinolines  were then lithiated using n-BuLi and  the lithioderivatives  were formylated using dry DMF to obtain 3-formylquinolines(4a-d). 

The key step in the present new approach is epoxidation of 3-formyl quinolines using dimethyl sulphonium methylide. This reaction revealed interesting findings. 3-Formyl-2,4-dimethoxyquinoline (4a) on reaction with ylide gave 2,4-dimethoxy-3-oxiranyl-quinolne (5a) and Dictamnine (1) while 4b-d on similar reaction gave a mixture of 3-oxiranylquinolines (5b-d) and 3-quinolinyl acetaldehydes (6b-d). 

Finally, 3-oxiranyl quinolines (5a-d) and 3-quinolinyl acetaldehydes (6b-d) were separately cyclised using polyphosphoric acid to furnish furoquinoline alkaloids, Dictamnine (1), Pteliene (2), Evolitrine (3) and -Fagarine (4). 

Chapter-II: New synthesis of chiral 2-hydroxy methyl-2,3-dihydro benzofurans and naphthofurans.

Substituted 2-hydroxymethyl-2,3-dihydrobenzofurans are an important class of naturally occurring oxygen heterocycles. Natural dihydrobenzofurans are shown to have a wide range of biological activities, which include antiseptic, anti diarrheal and anti cancer activities. There are couple of reports on the synthesis of chiral dihydro benzofurans. The present novel approach involves hydrolytic kinetic resolution using (R,R)(Salen)Co(III) (OAc), Jacobsen catalyst. The new route is outlined below (Scheme-II). 
Scheme-II




16a)   R1  = R2  = R4  = H;  R3  = NO2 ; 
16b)   R1 = R2  = R4  = H;  R3  = CH3; 
16c)   R1  = CH3; R2  = R4  = H; R3  = Cl; 


Scheme-III




Scheme-IV



In this new approach, phenols (7a-c) were converted to o-allyl phenols (8a-c) which were subjected to Claisen rearrangement in N N-diethyl aniline to give 9a-c. o-Allyl phenols were subsequently treated with benzyl bromide to afford O-benzyl derivatives (10a-c). Epoxidation of 10a-c using oxone gave racemic epoxides (11a-c) which were resolved by HKR, using (R,R) (Salen) Co(III) (OAc), Jacobsen catalyst and H2O. Hydrolytic kinetic resolution of racemic epoxides gave (-)(R)-epoxide and (+)(S)-diol (13a-c) which were separated by column chromatography. 

Cyclisation of racemic and (-)(R) epoxides separately in presence of 10% Pd-C in methanol and a catalytic amount of Et3N and potassiumcarbonate gave (+)(S)-2-hydroxymethyl-2,3-dihydro benzofurans 15a-c and 16a-c. 
	
In order to confirm the structure of 16b the same enantiomer was prepared by enantio selective kinetic resolution using lipase enzyme, a reported procedure. 16b showed optical rotation  = +20.00 (c 1.5% in CHCl3) where as the authentic sample showed optical rotation  = + 21.00 (c 1.5% in CHCl3). 

Similarly, 2-hydroxymethyl-2,3-dihydronaphtho[1,2-b]furans were prepared, in order to investigate their anti bacterial activity, against six bacterial strains. 

Chapter – III : Synthesis of 2-arylamino-4-(3-pyridyl)thiazole analogs using 
HMCM-41. 
A wide variety of applications have been proposed for 2-arylamino-4-(3-pyridyl) thiazoles. The main applications cover the fields of agriculture, pharmacy, 
and phototherapy or related activities. The pharmaceutical applications include 
antiviral, bactericidal and antimicrobial activities. More recently, ethyl 
3-[N-[4-[4-amino(ethoxycarbonyl)-imino]methyl]phenyl]-1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl] piperid-4-yl]amino] propionate was shown to be the most potent antiplatelet aggregation agent. IC50 = 46  1 nM. Therefore, it was planned to design similar analogs in order to investigate their antiplatelet aggregation activity. 

In this new approach, 2-arylamino-4-(3-pyridyl) thiazoles were prepared by condensation of 3-(-bromo) acetyl pyridine with aryl thioureas in presence of a mesoporous alumino silicate catalyst HMCM-41, based on a well known Hantzsch thiazole synthesis. The scheme follows as outlined below. 

Scheme-V 



Scheme-VI



33a) 	R1  =  R2  =  R3  =  R4  =  H; 
33b) 	R1  =  R2  =  R4  =  R5 =  H;  R3  = CH3; 
33c) 	R1  =  R2  =  R4 =  R5  =  H;  R3  = NO2; 
33d) 	R2  =  R3  =  R4  =  R5  =  H;  R1  = C2H5; 
33e) 	R2  =  R3  =  R4  =  R5  =  H;  R1  = F; 
33f) 	R1  =  R2  =  R4  =  R5  =  H;  R3  = n-butyl; 
33g) 	R2  =  R3  =  R4  =  H;   R1  =  R5  =  ethyl; 





Scheme-VII

33a) 	R1  =  R2  =  R3  =  R4  =  R5   = H; 
33b) 	R1  =  R2  =  R4  =  R5  =  H;  R3  = CH3; 
33c) 	R1  =  R2  =  R4  =  R5  =  H;  R3  = NO2; 
33d) 	R2  =  R3  =  R4  =  R5  =  H;  R1  = C2H5; 
33e) 	R2  =  R3  =  R4  =  R5  =  H;  R1  = F; 
33f) 	R1  =  R2  =  R4  =  R5  =  H;  R3  = n-butyl; 
33g) 	R2  =  R3  =  R4  =  H;   R1  =  R5  =  C2H5; 





Scheme-VIII


Acetyl pyridine (31) was prepared starting from nicotinic acid (28), which was converted to 3 (-bromo) acetyl pyridine hydrobromide salt (32) using Br2 in acetic acid. Aryl thioureas (34a-i) were prepared from arylamines and ammonium thiocyanate in 15% hydrochloric acid. Finally 3-(-bromo) acetyl pyridine (32) and aryl amines were condensed in presence of HMCM-41, a mesoporous alumino silicate catalyst. Being an acidic catalyst, HMCM-41 facilitates the condensation, thereby reaction time is reduced and yields were improved by 20%, when compared with the condensation in methanol alone (i.e. in absence of HMCM-41 catalyst). Finally, 2-amino-4-(3-pyridyl) thiazole (36j) was oxidised using m-chloroperbenzoic acid at 0C, to furnish the corresponding sulfoxy derivative (37). Formation of sulfoxide was identified by IR spectrum where it showed an absorption band at 1100 cm-1 due to S=O str. 

All the synthesized compounds were screened for anti platelet aggregation activity on human blood samples. 

Chapter–IV: This chapter was divided into two sections, Sections-A and Section B. 
Section A describes the ADP induced anti platelet aggregation activity of 2-aryl amino-4-(3-pyridyl) thiazoles on human blood samples. These experiments were carried out on Lumi aggregometer (Ca2+); CHRONOLOG carporation, Haverton, PA, USA at 37C. The platelet aggregation inhibitory activity was expressed in IC50. Among the test compounds, 2-(2-fluoro-phenyl) amino-4-(3-pyridyl)-thiazole was found to be the most potent compound with IC50 = 484 nM. Finally, QSAR studies were described for all the test compounds, and reported compounds. 

In Section B, the anti bacterial activity of optically active 2-hydroxy methyl 2,3-dihydro benzofurans and 2-hydroxy methyl-2,3-dihydro naphtho[1,2-b] furans was described against six bacterial strains. Among them (-)(R) 5-nitro-2-acetoxy methyl-2,3-dihydro benzofuran was found to be the most potent against Bacillus sphericus with 26 mm of disc diffusion rate at 100 g concentration which is higher than penicillin–G. (For penicillin-G, it is 23mm/100 g). Hence this compound has been selected as the candidate for development against Bacillus sphericus (MTCC 441). 
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